Hair loss sorts into three main stories. Pattern (androgenetic) loss — gradual thinning at temples/crown in men, a widening part in women — is follicle miniaturization under DHT and genetics; topical minoxidil (both sexes) and oral finasteride (men) are the proven treatments, working for as long as they're used. Telogen effluvium — sudden diffuse shedding 2–3 months after illness, childbirth, crash dieting, major stress or new medications — recovers on its own once the trigger passes. Patchy coin-shaped loss is alopecia areata, an autoimmune condition with its own treatments including new JAK inhibitors for severe cases. Iron and thyroid tests catch the fixable contributors; scarring types need urgent dermatology because destroyed follicles don't return.
Three stories, one complaint
1. Pattern (androgenetic) loss — the majority. Genetically susceptible follicles respond to DHT (dihydrotestosterone) by miniaturizing: each cycle produces a finer, shorter hair until the follicle idles. Men: receding temples and crown, the familiar map, beginning any time after puberty — half of men show it by 50. Women: diffuse widening of the central part with the frontal line preserved, commonest after menopause, with PCOS the young-onset flag. It is progressive but negotiable — the earlier treated, the more retained, since treatment preserves better than it rebuilds.
2. Telogen effluvium — the dramatic self-fixer. The FAQ's delayed mass-shed after systemic shocks: frightening volume, diffuse pattern, spontaneous regrowth in 6–12 months once the trigger (illness, childbirth, crash diets — the safe-rate page's warning made visible — stress, drugs including retinoids, beta-blockers, anticoagulants and stopped contraceptives) has passed. Treatment is cause-removal and patience; its chronic form and its unmasking of underlying pattern loss are the wrinkles a dermatologist irons out.
3. Alopecia areata — the autoimmune ambush. Smooth coin-shaped patches, sometimes eyebrows, lashes or nails (pitting) involved; unpredictable relapsing-remitting course; treatments from watchful waiting and steroid injections to the JAK-inhibitor tablets newly approved for severe disease — a genuine therapeutic breakthrough. Always a diagnosis-and-dermatologist condition, not a shampoo project.
The remainder that must not be missed: traction alopecia (tight styles — reversible early, permanent late), scarring alopecias (itch, burning, redness, lost follicle openings — urgent dermatology, since scarred follicles are gone), fungal scalp infection in children, trichotillomania, and the diffuse contributions of iron deficiency, thyroid disease, protein-crash dieting and medications that a short blood panel (ferritin, TSH, and androgens where the picture fits) either convicts or acquits.
Treatment, by evidence
Minoxidil (topical 5% foam/solution, both sexes; low-dose oral off-label via dermatologists): prolongs the growth phase and re-plumps miniaturizing follicles — trials show slowed loss and moderate regrowth in a substantial fraction, judged at 6–12 months, with an infamous temporary shed at weeks 4–8 that means it's working. It is rent, not purchase: benefits reverse within months of stopping.
Finasteride (1 mg oral, men): blocks the testosterone→DHT conversion, cutting scalp DHT ~60%; the best-evidenced intervention — trials show ~80–90% of men stop losing and a majority regrow visibly at the crown over 1–2 years, with the FAQ's honest side-effect accounting. Same rent economics. (Dutasteride, stronger, is used off-label in several countries; women's options per the FAQ.)
Supporting cast with real-if-modest files: low-level laser combs/caps (multiple small positive trials), ketoconazole shampoo as adjunct, platelet-rich plasma injections (growing but inconsistent evidence, cost-heavy), micro-needling alongside minoxidil, and hair transplantation — relocation of DHT-resistant donor follicles, permanent where done well, and best atop medical therapy that protects the non-transplanted territory.
The market behind the evidence — biotin, collagen, "DHT-blocking" botanical blends riding saw palmetto's thin oral file — is graded in the FAQ and the hub's product research, priced against a proven pair that costs less than most gummy subscriptions.
When to see a doctor
Promptly: patchy loss, any scalp redness/scaling/pain/itch with loss (scarring rule-out), loss with the iron or thyroid constellations, eyebrow/lash involvement, or childhood scalp disease. Routinely but sooner-is-better: pattern loss that bothers you (treatment preserves best early), shedding past six months, or female-pattern onset young enough to raise the PCOS question. And universally: photograph monthly under the same light — the follow-up tool every clinic wishes patients brought, and the only honest judge of whatever is tried.
Frequently asked questions
How much daily shedding is normal, and when is it "effluvium"?
Losing 50–100 hairs a day is normal turnover — visible on brushes and drains without meaning anything. Telogen effluvium is different in scale and story: handfuls, a suddenly thin ponytail, shedding at a touch — beginning a telltale 2–3 months after a trigger (high fever, COVID, surgery, childbirth, rapid weight loss, severe stress, stopping or starting certain drugs), because that's how long shocked follicles take to release. It sheds alarmingly, thins diffusely rather than patterning, and regrows over 6–12 months once the cause has passed.
Does finasteride really cause permanent sexual side effects?
In trials, sexual side effects (lower libido, erectile difficulty) occur in roughly 2–4% versus ~1–2% on placebo, and typically resolve on stopping or even continuing. A post-finasteride syndrome of persistent symptoms is reported and debated — plausible in a small minority, confounded in studies by expectation effects. Fair framing: a real but uncommon, usually reversible risk, weighed against the best-evidenced pill for a condition that otherwise progresses; topical finasteride and lower-frequency dosing exist as middle paths worth discussing.
Can women take finasteride, and what causes female pattern loss?
Female pattern loss is real and common — a widening part with preserved front line, accelerating after menopause — driven by genetics and androgen sensitivity, with PCOS the classic younger-onset flag. First-line is minoxidil (2% or 5%); finasteride is strictly contraindicated in pregnancy (birth-defect risk) and off-label with mixed evidence post-menopause; spironolactone is the commoner anti-androgen choice. The work-up matters more in women: iron, thyroid, and androgen testing where PCOS features appear.
Do hair-loss shampoos, biotin or "DHT-blocker" supplements work?
Ketoconazole shampoo has small supportive studies as an adjunct (and treats the flaky-scalp piece); caffeine shampoos have lab data and marketing. Biotin helps only true deficiency — rare — while distorting thyroid and cardiac lab tests. Saw palmetto's oral evidence is thin and inferior to finasteride wherever compared. The honest hierarchy: proven pair first, adjunct shampoo optionally, blood tests for causes — gummies last, if ever.
References
- MedlinePlus. Hair Loss (2023). https://medlineplus.gov/hairloss.html
- NIH Office of Dietary Supplements. Biotin — Fact Sheet for Health Professionals (2022). https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/
This page contains no product recommendations or affiliate links. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.